接受 PMRT/IMRT 的左侧乳腺癌患者深吸气屏气的选择标准和方法

IF 2.7 3区 医学 Q3 ONCOLOGY
Yingying Zhou , Jinfeng Xu , Fumin Xu , Yanning Li , Huali Li , Lisheng Pan , Yang Li , Shuyi Cao , Longmei Cai , Lin Yang , Bo Chen , Hongmei Wang
{"title":"接受 PMRT/IMRT 的左侧乳腺癌患者深吸气屏气的选择标准和方法","authors":"Yingying Zhou ,&nbsp;Jinfeng Xu ,&nbsp;Fumin Xu ,&nbsp;Yanning Li ,&nbsp;Huali Li ,&nbsp;Lisheng Pan ,&nbsp;Yang Li ,&nbsp;Shuyi Cao ,&nbsp;Longmei Cai ,&nbsp;Lin Yang ,&nbsp;Bo Chen ,&nbsp;Hongmei Wang","doi":"10.1016/j.ctro.2024.100812","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>This study explored whether a free-breathing mean heart dose (FB-MHD) of 4 Gy is a reliable dose threshold for selecting left breast cancer patients after modified radical mastectomy suitable for deep inspiration breath-hold (DIBH) and developed anatomical indicators to predict FB-MHD for rapid selection.</p></div><div><h3>Materials and methods</h3><p>Twenty-three patients with left breast cancer treated with DIBH were included to compare FB and DIBH plans. The patients were divided into the high-risk (FB-MHD ≥ 4 Gy) and low-risk (FB-MHD &lt; 4 Gy) groups to compare dose difference, normal tissue complication probability (NTCP) and the DIBH benefits. Another 30 patients with FB only were included to analyze the capacity of distinguishing high-risk heart doses patients according to anatomical metrics, such as cardiac-to-chest Euclidean distance (CCED), cardiac-to-chest gap (CCG), and cardiac-to-chest combination (CCC).</p></div><div><h3>Results</h3><p>All heart doses were significantly lower in patients with DIBH plans than in those with FB plans. Based on FB-MHD of 4 Gy cutoff, the heart dose, NTCP for cardiac death, and benefits from DIBH were significantly higher in the high-risk group than in the low-risk group. The CCED was a valid anatomical indicator with the largest area under the curve (AUC) of 0.83 and maintained 95 % sensitivity and 70 % specificity at the optimal cutoff value of 2.5 mm.</p></div><div><h3>Conclusions</h3><p>An FB-MHD of 4 Gy could be used as an efficient dose threshold for selecting patients suitable for DIBH. The CCED may allow a reliable prediction of FB-MHD in left breast cancer patients at CT simulation.</p></div>","PeriodicalId":10342,"journal":{"name":"Clinical and Translational Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405630824000892/pdfft?md5=0d5516f40ba3ab24dd8a634cb1fae08f&pid=1-s2.0-S2405630824000892-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Selection criteria and method for deep inspiration breath-hold in patients with left breast cancer undergoing PMRT/IMRT\",\"authors\":\"Yingying Zhou ,&nbsp;Jinfeng Xu ,&nbsp;Fumin Xu ,&nbsp;Yanning Li ,&nbsp;Huali Li ,&nbsp;Lisheng Pan ,&nbsp;Yang Li ,&nbsp;Shuyi Cao ,&nbsp;Longmei Cai ,&nbsp;Lin Yang ,&nbsp;Bo Chen ,&nbsp;Hongmei Wang\",\"doi\":\"10.1016/j.ctro.2024.100812\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>This study explored whether a free-breathing mean heart dose (FB-MHD) of 4 Gy is a reliable dose threshold for selecting left breast cancer patients after modified radical mastectomy suitable for deep inspiration breath-hold (DIBH) and developed anatomical indicators to predict FB-MHD for rapid selection.</p></div><div><h3>Materials and methods</h3><p>Twenty-three patients with left breast cancer treated with DIBH were included to compare FB and DIBH plans. The patients were divided into the high-risk (FB-MHD ≥ 4 Gy) and low-risk (FB-MHD &lt; 4 Gy) groups to compare dose difference, normal tissue complication probability (NTCP) and the DIBH benefits. Another 30 patients with FB only were included to analyze the capacity of distinguishing high-risk heart doses patients according to anatomical metrics, such as cardiac-to-chest Euclidean distance (CCED), cardiac-to-chest gap (CCG), and cardiac-to-chest combination (CCC).</p></div><div><h3>Results</h3><p>All heart doses were significantly lower in patients with DIBH plans than in those with FB plans. Based on FB-MHD of 4 Gy cutoff, the heart dose, NTCP for cardiac death, and benefits from DIBH were significantly higher in the high-risk group than in the low-risk group. The CCED was a valid anatomical indicator with the largest area under the curve (AUC) of 0.83 and maintained 95 % sensitivity and 70 % specificity at the optimal cutoff value of 2.5 mm.</p></div><div><h3>Conclusions</h3><p>An FB-MHD of 4 Gy could be used as an efficient dose threshold for selecting patients suitable for DIBH. The CCED may allow a reliable prediction of FB-MHD in left breast cancer patients at CT simulation.</p></div>\",\"PeriodicalId\":10342,\"journal\":{\"name\":\"Clinical and Translational Radiation Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-06-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2405630824000892/pdfft?md5=0d5516f40ba3ab24dd8a634cb1fae08f&pid=1-s2.0-S2405630824000892-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Translational Radiation Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405630824000892\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405630824000892","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

材料与方法纳入23例接受DIBH治疗的左乳腺癌患者,比较FB和DIBH方案。这些患者被分为高风险组(FB-MHD ≥ 4 Gy)和低风险组(FB-MHD < 4 Gy),以比较剂量差异、正常组织并发症概率(NTCP)和 DIBH 的益处。另外还纳入了30名仅接受FB治疗的患者,以分析根据解剖学指标(如心胸欧氏距离(CCED)、心胸间隙(CCG)和心胸组合(CCC))区分高风险心脏剂量患者的能力。根据 4 Gy 临界值的 FB-MHD 计算,高风险组的心脏剂量、心源性死亡的 NTCP 以及 DIBH 的获益均明显高于低风险组。CCED是一个有效的解剖指标,其最大的曲线下面积(AUC)为0.83,在最佳临界值2.5 mm时保持了95%的灵敏度和70%的特异性。CCED可以在CT模拟中可靠地预测左侧乳腺癌患者的FB-MHD。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Selection criteria and method for deep inspiration breath-hold in patients with left breast cancer undergoing PMRT/IMRT

Purpose

This study explored whether a free-breathing mean heart dose (FB-MHD) of 4 Gy is a reliable dose threshold for selecting left breast cancer patients after modified radical mastectomy suitable for deep inspiration breath-hold (DIBH) and developed anatomical indicators to predict FB-MHD for rapid selection.

Materials and methods

Twenty-three patients with left breast cancer treated with DIBH were included to compare FB and DIBH plans. The patients were divided into the high-risk (FB-MHD ≥ 4 Gy) and low-risk (FB-MHD < 4 Gy) groups to compare dose difference, normal tissue complication probability (NTCP) and the DIBH benefits. Another 30 patients with FB only were included to analyze the capacity of distinguishing high-risk heart doses patients according to anatomical metrics, such as cardiac-to-chest Euclidean distance (CCED), cardiac-to-chest gap (CCG), and cardiac-to-chest combination (CCC).

Results

All heart doses were significantly lower in patients with DIBH plans than in those with FB plans. Based on FB-MHD of 4 Gy cutoff, the heart dose, NTCP for cardiac death, and benefits from DIBH were significantly higher in the high-risk group than in the low-risk group. The CCED was a valid anatomical indicator with the largest area under the curve (AUC) of 0.83 and maintained 95 % sensitivity and 70 % specificity at the optimal cutoff value of 2.5 mm.

Conclusions

An FB-MHD of 4 Gy could be used as an efficient dose threshold for selecting patients suitable for DIBH. The CCED may allow a reliable prediction of FB-MHD in left breast cancer patients at CT simulation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
5.30
自引率
3.20%
发文量
114
审稿时长
40 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信